Bluejay Completes Patient Enrollment in SYMON-II Trial
Acton, Massachusetts, USA | July 21, 2026 Bluejay Diagnostics has announced the successful completion of patient enrollment in its...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
Acton, Massachusetts, USA | July 21, 2026 Bluejay Diagnostics has announced the successful completion of patient enrollment in its...
Conshohocken, Pennsylvania, USA | July 20, 2026 AdaptHealth Corp. has entered into a definitive agreement to sell its Diabetes...
San Diego, California, USA | July 21, 2026 Acadia Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA)...
Crystal Lake, Illinois, USA | July 20, 2026 Aptar Beauty has announced the commercial launch of NeoDropper Autoload, its...
ST. LOUIS, Missouri, USA | July 20, 2026 Stereotaxis announced the launch of Hungary’s first advanced robotic cardiology program...
Marseille, France | July 21, 2026 Innate Pharma SA has announced the completion of enrollment in the dose-escalation portion...
BOONE, N.C., July 20, 2026 Fuse Oncology has unveiled FuseRx, an innovative AI-powered prescribing and treatment-intent solution designed to...
RICHMOND, Va., July 20, 2026 Virginia’s Advanced Pharmaceutical Manufacturing (APM) Tech Hub has secured a $15.97 million investment from...
Berlin, Germany | July 21, 2026 OMEICOS announced that the U.S. Food and Drug Administration (FDA) has provided positive...
Riyadh, Saudi Arabia | July 21, 2026 King Faisal Specialist Hospital and Research Centre (KFSH) has achieved a global...
